iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
78 hedge funds and large institutions have $85.5M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.13% more ownership
Funds ownership: 19.58% → 26.71% (+7.1%)
Holders
78
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.33M | |
| 2 | +$4.46M | |
| 3 | +$2.96M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.57M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.24M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$1.23M | |
| 3 | -$1.13M | |
| 4 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
-$274K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$262K |